Meihua International Medical Technologies Co., Ltd.

NASDAQ:MHUA

0.6124 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 22.67222.67224.45424.45448.1924.09548.51324.25754.83327.41627.83827.83824.1824.1822.83622.83621.69521.69516.72616.72623.08723.087
Cost of Revenue 15.10415.10416.46716.46731.0915.53531.30715.68533.94117.00317.07517.14915.06715.06713.85713.85712.17112.17110.16310.16313.6313.63
Gross Profit 7.5687.5687.9877.98717.18.5617.2078.57120.89210.41310.76410.6899.1139.1138.9798.9799.5249.5246.5636.5639.4569.456
Gross Profit Ratio 0.3340.3340.3270.3270.3550.3550.3550.3530.3810.380.3870.3840.3770.3770.3930.3930.4390.4390.3920.3920.410.41
Reseach & Development Expenses 0.730.730.6460.6461.4550.731.3210.661.6420.8210.6550.6550.7080.7080.6050.6050.6410.6410.8130.8130.7940.794
General & Administrative Expenses 1.7231.7231.5171.5171.6981.6983.8023.8022.3632.3631.0920.9971.0621.0621.1951.1951.0071.0071.0161.0160.990.99
Selling & Marketing Expenses 1.61.62.0672.0671.5811.5811.8991.8991.6561.6561.6361.6361.5931.5931.8511.8511.4611.4611.4031.4031.31.3
SG&A 3.8923.8924.5524.5526.2463.28213.7535.70110.5814.0232.7182.6442.6652.6653.0463.0462.4782.4782.4172.4172.3022.302
Other Expenses -0-0-0.2830-0.30200000000000000000
Operating Expenses 4.6224.6225.2065.2068.0034.12915.0737.59412.2235.8793.3313.2563.3533.3533.3983.3983.1883.1883.2733.2733.0983.098
Operating Income 2.9462.9462.7892.7899.0974.5482.1332.218.6695.5697.3917.3915.745.745.3275.3276.4066.4063.3333.3336.3616.361
Operating Income Ratio 0.130.130.1140.1140.1890.1890.0440.0910.1580.2030.2650.2650.2370.2370.2330.2330.2950.2950.1990.1990.2760.276
Total Other Income Expenses Net -0.003-0.0030.1870.187-0.001-0-0.231-1.2580.32-1.0750.0010.001-0.018-0.0180.2240.224-0.091-0.091-0.049-0.049-0.02-0.02
Income Before Tax 2.9432.9432.9772.9779.0964.5481.9030.9518.9894.4947.3927.3925.7225.7225.5525.5526.3156.3153.2843.2846.3416.341
Income Before Tax Ratio 0.130.130.1220.1220.1890.1890.0390.0390.1640.1640.2660.2660.2370.2370.2430.2430.2910.2910.1960.1960.2750.275
Income Tax Expense 0.5880.5880.6970.6972.0641.0322.281.142.4341.2171.4641.4641.1761.1761.1281.1281.2161.2160.6570.6571.2531.253
Net Income 2.3582.3582.2822.2827.0623.531-0.312-0.1566.5553.2775.9295.9294.5464.5464.4244.4245.0995.0992.6272.6275.0895.089
Net Income Ratio 0.1040.1040.0930.0930.1470.147-0.006-0.0060.120.120.2130.2130.1880.1880.1940.1940.2350.2350.1570.1570.220.22
EPS 0.0850.0850.0950.0950.30.15-0.013-0.0070.290.140.30.30.230.230.210.210.270.270.130.130.250.25
EPS Diluted 0.0770.0770.0950.0950.30.15-0.013-0.0070.290.140.30.30.230.230.210.210.270.270.130.130.250.25
EBITDA 3.0923.0922.8762.8769.44.6972.3652.3655.6965.6967.5437.5435.8995.8995.4735.4736.5226.5223.4583.4586.496.49
EBITDA Ratio 0.1360.1360.1180.1180.1950.1950.0490.0970.1040.2080.2710.2710.2440.2440.240.240.3010.3010.2070.2070.2810.281